L-Citrulline Versus Tamsulosin for Medical Expulsive Therapy of Distal Ureteral Stones
Recruiting
Phase 2
Interventional Study
Distal Ureteral Stone
Urolithiasis
Ureteral Calculi
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 60
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 120 (estimated)
- Sponsor
- Beni-Suef University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study will compare L-citrulline and tamsulosin as medical expulsive therapy for adults with single distal ureteral stones.
Eligible participants with a single distal ureteral stone measuring 5 to 10 mm will be randomly assigned to receive either oral L-citrulline 750 mg twice daily or oral tamsulosin 0.4 mg once daily. Treatment will continue until documented stone passage or completion of 4…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults aged 18 to 60 years.
* Single distal ureteral stone.
* Stone size 5 to 10 mm.
* Normal renal function.
* Controlled pain.
* Willingness to comply with follow-up for 4 weeks.
* Written informed consent.
Exclusion Criteria:
* Fever or active urinary tract infection.
* S…
Contacts